In a separate study involving young children ages 2 months through 5 years, glycerol phenylbutyrate resulted in a more evenly distributed urinary output of PAGN over 24 hours and accounted for fewer symptoms from accumulation of phenylacetate.
A separate study involving young children aged 2 months to 5 years demonstrated that glycerol phenylbutyrate resulted in a more even distribution of PAGN over 24 hours and reduced symptoms from phenylacetate accumulation.